Oncolytics Biotech(R) Announces First Patient Treated in Company’s AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer
- Study to generate comprehensive biomarker data by breast cancer sub-type to support phase 3 registration program - Interim data...